Isolation And Characterization Of A Novel Lytic Bacteriophage Against Staphylococcus Aureus | 34006
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand
Google scholar citation report
Citations : 1536

Journal of Biotechnology & Biomaterials received 1536 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Isolation and characterization of a novel lytic bacteriophage against Staphylococcus aureus

8th Euro Biotechnology Congress

Zsolt Doffkay1, Dóra Dömötör2, György Schneider3, Tamás Kovács2 and Gábor Rákhely1

1University of Szeged, Hungary 2Enviroinvest Corp., Hungary 3University of Pécs, Hungary

Posters-Accepted Abstracts: Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.038

The emergence of antibiotic resistant bacteria is one of the current greatest challenges of the healthcare system. Since multidrug-resistancy is rapidly spreading, development of novel antibiotics is not a feasible strategy. Therefore, new alternative antimicrobial agents are necessary. Using bacteriophages – the natural enemies of bacteria – is a promising alternative approach. Bacteriophages (phages) are viruses that are obligate intracellular parasites of bacteria, which could be applied to control also multidrug resistant bacteria. The consortium of Enviroinvest Co., University of Pécs and University of Szeged established a scientific center in order to develop phage therapeutic products against human-, animal- and plant pathogenic bacteria. Staphylococcus aureus, is a Gram-positive bacterium which is responsible for numerous infections worldwide. The emergence methicillin-resistant (MRSA) and vancomycin-resistant (VRSA) cell lines made the treatment of S. aureus infections more difficult. The aim of this research was to find effective bacteriophages against S. aureus. Several potential candidates were isolated. Lysogenic bacteriophages are not suitable for therapeutic use, therefore our research focused on strictly lytic ones. Few candidates have been found which had strictly lytic phenotype. In order to use them in bacteriophage therapy, their morpoholgical characters, maximal titer, lytic spectra/host specificity and genomic sequence must be determined. Therefore, we have sequenced the viral genomes. In one lytic phage, several spontaneous mutations in the integrase gene could be recognized. These mutations could account for the strictly lytic phenotype of the bacteriophage. The complete genome sequence also allowed us to compare the new phage with previously sequenced ones.

Zsolt Doffkay has completed his MSc degree and studied at University of Szeged, Faculty of Science and Informatics as biologist (Molecular-, Immun- and Microbiology specialization). He started his PhD programme at Doctoral School of Biology in 2013 and his supervisor is Dr. Gábor Rákhely.

Email: [email protected]